335 related articles for article (PubMed ID: 26134029)
1. L-type amino acid transporter-1 and CD98 expression in bone and soft tissue tumors.
Koshi H; Sano T; Handa T; Yanagawa T; Saitou K; Nagamori S; Kanai Y; Takagishi K; Oyama T
Pathol Int; 2015 Sep; 65(9):460-7. PubMed ID: 26134029
[TBL] [Abstract][Full Text] [Related]
2. l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Tanaka S; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Cancer Sci; 2008 Dec; 99(12):2380-6. PubMed ID: 19018776
[TBL] [Abstract][Full Text] [Related]
3. CD98 as a novel prognostic indicator for patients with stage III/IV hypopharyngeal squamous cell carcinoma.
Toyoda M; Kaira K; Shino M; Sakakura K; Takahashi K; Takayasu Y; Tominaga H; Oriuchi N; Nikkuni O; Suzuki M; Iijima M; Tsukamoto N; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
Head Neck; 2015 Nov; 37(11):1569-74. PubMed ID: 24913970
[TBL] [Abstract][Full Text] [Related]
4. Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis.
Furuya M; Horiguchi J; Nakajima H; Kanai Y; Oyama T
Cancer Sci; 2012 Feb; 103(2):382-9. PubMed ID: 22077314
[TBL] [Abstract][Full Text] [Related]
5. Differential expression and functional characterization of system L amino acid transporters in human normal osteoblast cells and osteogenic sarcoma cells.
Kim SG; Kim HH; Kim HK; Kim CH; Chun HS; Kanai Y; Endou H; Kim DK
Anticancer Res; 2006; 26(3A):1989-96. PubMed ID: 16827134
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma.
Shimizu A; Kaira K; Kato M; Yasuda M; Takahashi A; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Asao T; Ishikawa O
Melanoma Res; 2015 Oct; 25(5):399-405. PubMed ID: 26237765
[TBL] [Abstract][Full Text] [Related]
7. [An analysis of autopsy cases of malignant soft tissue and bone tumors].
Enjoji M; Hashimoto H; Yamamoto I; Daimaru Y
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1931-6. PubMed ID: 2543328
[TBL] [Abstract][Full Text] [Related]
8. TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms.
Kosemehmetoglu K; Vrana JA; Folpe AL
Mod Pathol; 2009 Jul; 22(7):872-8. PubMed ID: 19363472
[TBL] [Abstract][Full Text] [Related]
9. Expression of E-cadherin in bone and soft tissue sarcomas: a possible role in epithelial differentiation.
Sato H; Hasegawa T; Abe Y; Sakai H; Hirohashi S
Hum Pathol; 1999 Nov; 30(11):1344-9. PubMed ID: 10571515
[TBL] [Abstract][Full Text] [Related]
10. Exfoliative cytology of malignant lymphoreticular, soft tissue, and bone neoplasms.
Hajdu SI; Hajdu EO
Pathol Annu; 1976; 11():317-34. PubMed ID: 188003
[No Abstract] [Full Text] [Related]
11. CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Kamide Y; Ishizuka T; Kanai Y; Nakajima T; Mori M
Ann Surg Oncol; 2009 Dec; 16(12):3473-81. PubMed ID: 19777189
[TBL] [Abstract][Full Text] [Related]
12. p63 expression in giant cell-containing lesions of bone and soft tissue.
de la Roza G
Arch Pathol Lab Med; 2011 Jun; 135(6):776-9. PubMed ID: 21631272
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Nakajima T; Mori M
Lung Cancer; 2009 Oct; 66(1):120-6. PubMed ID: 19171406
[TBL] [Abstract][Full Text] [Related]
14. LHRH receptor expression in sarcomas of bone and soft tissue.
Deivaraju C; Temple HT; Block N; Robinson P; Schally AV
Horm Mol Biol Clin Investig; 2016 Nov; 28(2):105-111. PubMed ID: 27639272
[TBL] [Abstract][Full Text] [Related]
15. [Expression of TEIF protein in soft tissue tumors and its significance].
Gong YL; Li T; Guo H; Sun Y; Chi YK; Ling Y; Shen Q; Liu HJ; Hou L; Zhang B
Zhonghua Bing Li Xue Za Zhi; 2006 Nov; 35(11):651-5. PubMed ID: 17374207
[TBL] [Abstract][Full Text] [Related]
16. SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours.
Conner JR; Hornick JL
Histopathology; 2013 Jul; 63(1):36-49. PubMed ID: 23701429
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Cancer Sci; 2009 Feb; 100(2):248-54. PubMed ID: 19068093
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of LAT1 and CD98 expression in cutaneous angiosarcoma.
Shimizu A; Kaira K; Okubo Y; Utsumi D; Yasuda M; Tominaga H; Oriuchi N; Kanai Y; Takahashi K; Ishikawa O
Neoplasma; 2017; 64(2):283-288. PubMed ID: 28052681
[TBL] [Abstract][Full Text] [Related]
19. Stem cell transcription factor SOX2 in synovial sarcoma and other soft tissue tumors.
Zayed H; Petersen I
Pathol Res Pract; 2018 Jul; 214(7):1000-1007. PubMed ID: 29773426
[TBL] [Abstract][Full Text] [Related]
20. Expression of PSMA in tumor neovasculature of high grade sarcomas including synovial sarcoma, rhabdomyosarcoma, undifferentiated sarcoma and MPNST.
Heitkötter B; Trautmann M; Grünewald I; Bögemann M; Rahbar K; Gevensleben H; Wardelmann E; Hartmann W; Steinestel K; Huss S
Oncotarget; 2017 Jan; 8(3):4268-4276. PubMed ID: 28002805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
